Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRAP - Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.

NCT03644303 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT03644303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03644303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRAP - Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Not applicable
Overall status
Completed
Start date
August 13, 2018
Completion date
March 31, 2025
Enrollment
86 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumour dna, metastasis, prostate cancer, toxicity due to radiotherapy